Lovastatin (Mevinolin)

Analytical studies confirmed lovastatin concentrations up to 2.8% dry weight in P. eryngii gills (lamellae), with lower concentrations in stipes and caps. A hypercholesterolemic rat model using 5% P. eryngii fruiting body powder achieved 62.5% LDL-cholesterol reduction, 46.3% triglyceride reduction, and 24.1% total cholesterol reduction over the study period. A six-week mouse safety study at 2000 mg/kg showed no adverse effects on body weight, food intake, serum biochemistry, or organ histology. Human intervention trials with related Pleurotus species (P. ostreatus, 30 g dried daily for 21 days) showed cholesterol metabolism improvements. A systematic review of 8 clinical trials confirmed beneficial effects on glucose and lipid metabolism.

P. ostreatus was confirmed as a natural source of lovastatin in the 1980s, and the compound was originally isolated from Aspergillus terreus for pharmaceutical development. A clinical study involving 20 adults consuming 30 g of dried oyster mushrooms daily for 21 days demonstrated significant reductions in triacylglycerol concentrations and oxidized LDL levels. Animal studies in hypercholesterolemic rats fed oyster mushroom diets showed significant improvements in lipid profiles. Lovastatin content varies by substrate and cultivation conditions, typically ranging from 0.7-2.8 mg/g dry weight.